Abbott Snaps Up Evalve In $410M Deal

Law360, New York (September 10, 2009, 6:12 PM EDT) -- Abbott Laboratories said Thursday it had agreed to acquire cardiac device maker Evalve Inc. in a $410 million deal meant to expand the company’s reach in the market for minimally invasive repair of cardiac mitral valves.

The agreement includes an upfront payment of $320 million in cash, plus an additional payment upon completion of certain regulatory milestones, for a total of up to $410 million, Abbott said.

According to Abbott, the deal will boost its presence in the growing area of nonsurgical treatment for structural heart...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.